Skip to main content
Log in

Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

We aimed to assess the long-term outcomes of biliopancreatic diversion (BPD) surgery on glycemic control, insulin sensitivity (IS), and beta cell function using complementary oral and intravenous dynamic tests.

Methods

A total of 57 women were divided into three groups: 19 lean, 18 obese (both groups with normal glucose tolerance (NGT)), and 20 obese with type 2 diabetes who underwent BPD and were reassessed 12 months after the procedure. OGTTs and hyperglycemic clamps (HG) were performed. Mathematical modeling was used to analyze IS, beta cell function, and delayed time of beta cell response. The basal, dynamic (first phase/steps of insulin secretion), and static (second phase/steps of insulin secretion) disposition indexes were calculated.

Results

After surgery, the patients exhibited improvements in glycemic control and 15 patients achieved diabetes remission. The surgical patients demonstrated normalized IS in OGGT and HG tests compared to the control groups. The basal beta cell function was improved but remained impaired compared to the Lean NGT group. The stimulated beta cell function parameters showed marked improvements regarding the intravenous stimulus and the second phase/distal steps of insulin secretion. The delay time markedly decreased and became normalized in both dynamic tests.

Conclusions

The common physiopathology features of type 2 diabetes, i.e., impaired IS and beta cell dysfunction, were demonstrated to be primarily functional and were likely to be reversible to some degree after the BPD. The marked long-term improvement in glycemic control after BPD was closely related to IS improvement and mainly by the recovery of several beta cell physiological features.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia. 2004;47(5):943–56.

    Article  CAS  PubMed  Google Scholar 

  2. Ferrannini E, Mari A. beta-Cell function in type 2 diabetes. Metabolism. 2014;63(10):1217–27.

    Article  CAS  PubMed  Google Scholar 

  3. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24(3):437–55.

    Article  CAS  PubMed  Google Scholar 

  4. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.

    Article  PubMed  Google Scholar 

  5. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52(5):1098–103.

    Article  CAS  PubMed  Google Scholar 

  6. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55(7):2025–31.

    Article  CAS  PubMed  Google Scholar 

  7. Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49(9):2136–43.

    Article  CAS  PubMed  Google Scholar 

  8. Briatore L, Salani B, Andraghetti G, et al. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity. 2008;16(1):77–81.

    Article  PubMed  Google Scholar 

  9. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32(3):375–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Briatore L, Salani B, Andraghetti G, et al. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obesity. 2010;18(5):932–6.

    Article  CAS  PubMed  Google Scholar 

  11. Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21(7):880–8.

    Article  PubMed  Google Scholar 

  12. Astiarraga B, Gastaldelli A, Muscelli E, et al. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab. 2013;98(7):2765–73.

    Article  CAS  PubMed  Google Scholar 

  13. Plourde CE, Grenier-Larouche T, Caron-Dorval D, et al. Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction. Obesity. 2014;22(8):1838–46.

    Article  CAS  PubMed  Google Scholar 

  14. Camastra S, Manco M, Mari A, et al. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care. 2007;30(4):1002–4.

    Article  CAS  PubMed  Google Scholar 

  15. Junqueira Vasques AC, Pareja JC, de Oliveira MS, et al. Beta-Cell function improvements in grade I/II obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies. Diabetes Care. 2013;36(12):4117–24.

    Article  PubMed  PubMed Central  Google Scholar 

  16. American Diabets Association. Executive summary: Standards of medical care in diabetes–2012. Diabetes Care. 2012;35 Suppl 1:S4–S10.

  17. Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.

    Article  CAS  PubMed  Google Scholar 

  18. Breda E, Cavaghan MK, Toffolo G, et al. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes. 2001;50(1):150–8.

    Article  CAS  PubMed  Google Scholar 

  19. Mitrakou A, Vuorinen-Markkola H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab. 1992;75(2):379–82.

    CAS  PubMed  Google Scholar 

  20. Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng. 2002;49(5):419–29.

    Article  PubMed  Google Scholar 

  21. Cobelli C, Caumo A, Omenetto M. Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol. 1999;277(3 Pt 1):E481–8.

    CAS  PubMed  Google Scholar 

  22. Cobelli C, Toffolo GM, Dalla Man C, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab. 2007;293(1):E1–E15.

    Article  CAS  PubMed  Google Scholar 

  23. Castagneto M, Mingrone G. The effect of gastrointestinal surgery on insulin resistance and insulin secretion. Curr Atheroscler Rep. 2012;14(6):624–30.

    Article  CAS  PubMed  Google Scholar 

  24. Novaes FS, Vasques AC, Pareja JC, et al. Recovery of the Incretin Effect in Type 2 Diabetic Patients After Biliopancreatic Diversion. J Clin Endocrinol Metab. 2015;100(5):1984–8.

  25. Yu J, Zhou X, Li L, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25(1):143–58.

    Article  PubMed  Google Scholar 

  26. Mas-Lorenzo A, Benaiges D, Flores-Le-Roux JA, et al. Impact of different criteria on type 2 diabetes remission rate after bariatric surgery. Obes Surg. 2014;24(11):1881–7.

    Article  CAS  PubMed  Google Scholar 

  27. Camerini GB, Papadia FS, Carlini F, et al. The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. Surg Obes Relat Dis. 2016;12(2):345–9.

  28. Ballesteros-Pomar MD, Gonzalez de Francisco T, Urioste-Fondo A, et al. Biliopancreatic diversion for severe obesity: long-term effectiveness and nutritional complications. Obes Surg. 2016;26(1):38–44.

    Article  PubMed  Google Scholar 

  29. Curro G, Centorrino T, Cogliandolo A, et al. A clinical and nutritional comparison of biliopancreatic diversion performed with different common and alimentary channel lengths. Obes Surg. 2015;25(1):45–9.

    Article  PubMed  Google Scholar 

  30. Hirsch FF, Pareja JC, Geloneze SR, et al. Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes. Obes Surg. 2012;22(6):910–7.

    Article  PubMed  Google Scholar 

  31. Fellici AC, Lambert G, Lima MM, et al. Surgical treatment of type 2 diabetes in subjects with mild obesity: mechanisms underlying metabolic improvements. Obes Surg. 2015;25(1):36–44.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Carolina Junqueira Vasques.

Ethics declarations

Funding

São Paulo Research Foundation - FAPESP, grants 2008/09451-7, 2008/07312-0, and 15/07900-2.

Conflict of Interest

The authors Ana Carolina J. Vasques, José C. Pareja, Maria da S. de Oliveira, Fernanda S. Novaes, Marcelo M. O. Lima, Élinton A. Chaim, Francesca Picinini, Chiara D. Man, Claudio Cobelli, and Bruno Geloneze declare that they have no conflict of interest.

Statement of Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vasques, A.C.J., Pareja, J.C., da Saúde de Oliveira, M. et al. Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function. OBES SURG 26, 2572–2580 (2016). https://doi.org/10.1007/s11695-016-2159-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-016-2159-3

Keywords

Navigation